Healthcare
HTGF and Bayern Kapital back Photonics Healthcare
High-Tech Gründerfonds (HTGF) and Bayern Kapital have backed Photonics Healthcare, a medical equipment manufacturer.
GED sells Grupo Sendal, reaps 2x return
GED has sold its stake in healthcare service provider Grupo Sendal to US-based Carefusion and reaped a 2x return.
Auven's ADC Therapeutics receives $40m funding round
Pharmaceuticals company ADC Therapeutics has raised $40m from existing backer Auven Therapeutics and corporation MedImmune.
Auven sells Spirogen in $240m trade sale
Auven Therapeutics has sold cancer drug pharmaceutical company Spirogen to US listed corporation AstraZeneca's subsidiary MedImmune for $240m.
immatics raises €34m series-D financing round
immatics biotechnologies, a biopharmaceutical firm, has raised €34m from existing investors including Wellington Partners and MIG.
Albion invests in Cisiv
Albion Ventures has invested in healthcare software-as-a-service business Cisiv.
Merck could turn to private equity to finance clinical trials
German pharmaceutical company Merck has held talks with private equity firms to potentially finance future clinical trials, according to reports.
Almi Invest backs Peptonic
Venture capital firm Almi Invest has taken a stake in Swedish pharmaceutical company Peptonic.
Almi Invest backs Avalanche Biotech
Almi Invest and business angel Pär Ribbner have invested in Swedish life sciences business Avalanche Biotech in exchange for a minority stake in the company.
Doughty's Quirón buys Teknon from Magnum
Magnum Industrial Partners has sold Barcelona-based private medical clinic Centro Médico Teknon to Grupo Hospitalario Quirón, backed by Doughty Hanson, for €225m.
Mir Capital buys Lima Corporate stake
Mir Capital has completed its second investment with the acquisition of a non-controlling stake in orthopaedic devices producer Lima Corporate from IMI Investimenti.
PE backers mull Ceva Santé Animale sale
French veterinary laboratory Ceva Santé Animale, backed by Nixen, Euromezzanine and Sagard, has mandated Lazard to explore the possibility of a sale in the first half of 2014.
Investinor, Industrifonden invest SEK 96m in Pharmalink
Pharmalink has received SEK 96m in a series-C financing round co-led by existing investor Industrifonden and new backer Investinor.
VC-backed Merus secures additional €31m
Dutch biopharma company Merus has received a €31m extension of its 2010 series-B funding round from Johnson & Johnson Development Corporation (JJDC) and its existing venture capital backers.
Omnes injects €3m into Opsona
Omnes Capital has made a capital injection of €3m into immunology drug developer Opsona Therapeutics, in an extension of the company’s series-C round.
Avista and Nordic Capital make tender offer for Acino
Avista Capital Partners and Nordic Capital have made a public tender offer for pharmaceutical company Acino.
Sherpa Capital buys Grupo Indo
Spanish turnaround investor Sherpa Capital has made a binding offer to acquire the production unit of ophthalmic lenses company Grupo Indo, after it hit bankruptcy in 2010.
VCs keep finger on the pulse of healthcare tech
Healthcare tech
BPI France et al. fund new French biotech
BPI France, Ixo Private Equity and the Irdinov fund have backed the creation of new French biotech firm GamaMabs Pharma with a €3.1m investment, working in partnership with French pharma group LFB.
IBB backs Myelo Therapeutics in series-A
IBB Beteiligungsgesellschaft has backed a series-A financing round for pharmaceutical company Myelo Therapeutics.
Sofinnova et al. invest £1.3m in Synthace
Sofinnova Partners has led a £1.3m funding round for Synthace, a London-based applied synthetic bioengineering company, alongside a syndicate of angel investors.
KfW backs Bill & Melinda Gates Foundation fund with €10m
German development bank KfW has invested €10m in the Global Health Investment Fund (GHIF) of the Bill & Melinda Gates Foundation, joining backers including JP Morgan and GlaxoSmithKline.
Sovereign looking to sell City & County
Sovereign Capital has hired Panmure Gordon to handle the sales process of care home company City & County.
French VCs invest €12m in Fermentalg
BPI France, Viveris Management and IRDI have taken part in a €12m fundraising round for biotechnology company Fermentalg, alongside existing investors.